On the Therapy of Disturbances of Blood Fluidity

Mueller, Roland
April 1985
Angiology;Apr1985, Vol. 36 Issue 4, p226
Academic Journal
Physiology and pathophysiology of blood fluidity are reviewed focussing the clinical relevance of the different hyperviscosity syndroms with particular respect to the microcirculation and thromboembolic complications. A new therapeutical approach is presented with pentoxifylline*, a drug which largely satisfies the complex requirements of a compound affecting most of the determinants of disturbed blood fluidity. The presented data of the multifunctional pharmacological properties of pentoxifylline on blood components and vessel wall suggest this drug as indicated for the treatment of the disorders of blood fluidity linked with many diseases. Its antihemostasiological and antithrombotic potential also offers the facility for prevention of postoperative thrombotic events and in vessel surgery to avoid reocclusion.


Related Articles

  • Cerebral Perfusion Changes in Older Delirious Patients Using 99mTc HMPAO SPECT. Fong, Tamara G.; Bogardus Jr., Sidney T.; Daftary, Aditya; Auerbach, Eliza; Blumenfeld, Hal; Modur, Sharada; Leo-Summers, Linda; Seibyl, John; Inouye, Sharon K. // Journals of Gerontology Series A: Biological Sciences & Medical ;Dec2006, Vol. 61A Issue 12, p1294 

    Background. Prior studies describe variable cerebral blood flow changes in delirium. This study aims to investigate cerebral blood flow changes in older hospitalized patients with delirium, the population in which most cases of delirium occur. Methods. Participants included hospitalized general...

  • Pentoxifylline and Intermittent Claudication. Spittell, John A. // Annals of Internal Medicine;Jan85, Vol. 102 Issue 1, p126 

    Reports that the U.S. Food and Drug Administration approved as of January 1985, the use of pentoxifylline, a methylxanthine with vasoactive properties for the symptomatic treatment of intermittent claudication due to chronic occlusive peripheral arterial disease. Recommended dose; Alternative...

  • Complex Regional Pain Syndrome: A Clinical Review. Siddiqui, Meraj N; Siddiqui, Shazia M; Ranasinghe, J. Sue; Furgang, Fred // Internet Journal of Pain, Symptom Control & Palliative Care;2001, Vol. 2 Issue 1, p7 

    Complex regional pain syndrome is the most complicated neuropathic type pain syndrome. The pathophysiology of the disease is poorly understood and the treatment mostly based on anicdotal experience. In this article we tried to explain the possible pathophysiological mechanisms of the disease and...

  • Evaluation of the Effects of Vasoactive Drugs on Cutaneous Microcirculation by Laser Doppler Velocimetry. Leonardo, Giuseppe; Arpaia, Maria Rosaria; Del Guercio, Raffaele // Angiology;Jan1986, Vol. 37 Issue 1, p12 

    The effects provoked in different points of skin circulation by a vasoactive drug injected in the femoral artery of patients affected by chronic obliterative arterial disease at clinical stage 2, were evaluated using the laser Doppler velocimeter. At the same time, by means of strain gauge...

  • Mechanisms of Raynaud's disease. Cooke, John P.; Marshall, Janice M. // Vascular Medicine;2005, Vol. 10 Issue 4, p293 

    Raynaud's phenomenon is due to transient cessation of blood flow to the digits of the hands or feet. An attack of Raynaud's phenomenon is classically manifested as triphasic color changes. The white phase is due to excessive vasoconstriction and cessation of regional blood flow. This phase is...

  • Antiproliferative and Antiproteolytic activity of Pentoxifylline in cultures of B16F10 Melanoma cells. Dua, Pooja; Gude, Rajiv P. // Cancer Chemotherapy & Pharmacology;Aug2006, Vol. 58 Issue 2, p195 

    Purpose: Pentoxifylline (PTX), a methyl xanthine derivative is widely used as a haemorheological agent in the treatment of peripheral vascular disease. In the present study, we investigated the in vitro effects of PTX on B16F10 melanoma cell proliferation, adhesion and secretion of Matrix...

  • Photoplethysmographic Documentation of Improved Microcirculation After Pentoxifylline Therapy. Roeren, Thomas; LeVeen, Robert F.; Nugent, Loree // Angiology;Nov1988, Vol. 39 Issue 11, p929 

    Pentoxifylline is the prototype of a new class of drugs that improve peripheral blood flow mainly by increasing red blood cell flexibility. Few studies have been performed to objectively evaluate the effect of the drug in a routine clinical setting. In 11 patients with intermittent claudication,...

  • A Comparison Between Aspirin and Pentoxifylline in Relieving Claudication Due to Peripheral Vascular Disease in the Elderly. Ciocon, Jerry O.; Galindo-Ciocon, Daisy; Galindo, Diana J. // Angiology;Mar1997, Vol. 48 Issue 3, p237 

    Peripheral vascular disease (PVD) commonly presents with leg claudication during walking and eventually limits the walking distance and daily activities. Aspirin or pentoxifylline are commonly prescribed to improve blood flow. Aspirin works through its antiplatelet aggregation mechanism, and...

  • Neurotrophins - From Pathophysiology to Treatment in Alzheimer's Disease. Schulte-Herbr�ggen, Olaf; Jockers-Scher�bl, Maria C.; Hellweg, Rainer // Current Alzheimer Research;Jan2008, Vol. 5 Issue 1, p38 

    Alzheimer's disease (AD) is the most common diagnosis among dementia. As increasing longevity results in larger numbers of AD patients and thus rising economic costs, there has been intense research about the pathophysiology and treatment strategies during the last years. Since neurotrophic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics